The effects of medication supply on hospitalizations and health-care costs in patients with chronic heart failure.

OBJECTIVES Use of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers results in decreased morbidity among patients with chronic heart failure (CHF). Undersupply of medication could result in inadequate control of CHF, whereas oversupply of medication could increase health-care costs and risks of toxicities. This study aimed to determine the effects of medication supplies on health-care costs and hospitalizations in patients with CHF receiving angiotensin-converting enzyme inhibitors or angiotensin receptor blockers. METHODS We retrospectively examined the electronic database in a hospital in Thailand. Patients who were diagnosed with CHF and who received angiotensin-converting enzyme inhibitors or angiotensin receptor blockers in the year 2003 were included. Medication supplies were assessed by using the medication possession ratio (MPR). The Cox proportional hazard model was used to determine the association of medication supply (appropriate supply: MPR 0.8-1.2, oversupply: MPR > 1.2, undersupply: MPR < 0.8) with CHF-related and all-cause hospitalizations. Health-care costs were compared by using multiple linear regressions. All analyses were adjusted for propensity score and other variables. RESULTS A total of 393 patients were included. Their mean age was 66 years, with 56% being females. Fifty-seven percent of the patients received an inappropriate -supply of medication. Undersupply of medication likely increased the risks of CHF-related hospitalization with an adjusted hazard ratio of 1.66 (95% confidence interval [CI] 0.80-3.46). The adjusted hazard ratio of undersupply and oversupply of medication for all-cause hospitalization was 1.13 (95% CI 0.74-1.73) and 3.19 (95%CI 0.66-15.47), respectively. The total health-care costs in the undersupply and oversupply groups were significantly greater than that in the appropriate-supply group: $49 (95% CI 32-66) and $103 (95% CI 32-173), respectively. CONCLUSIONS Inappropriate medication supplies could increase the risks of CHF-related and all-cause hospitalizations. Both undersupply and oversupply of medication had significantly higher health-care costs.

[1]  H. Liedholm,et al.  Health care costs of heart failure: results from a randomised study of patient education , 2000, European journal of heart failure.

[2]  K. Furie,et al.  Heart disease and stroke statistics--2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. , 2007, Circulation.

[3]  D. J. Veldhuisen,et al.  Non‐compliance in patients with heart failure; how can we manage it? , 2005, European journal of heart failure.

[4]  H. Bosworth,et al.  Medication Acquisition and Self-Reported Adherence in Veterans With Hypertension , 2009, Medical care.

[5]  A. Hoes,et al.  Clinical epidemiology of heart failure , 2007, Heart.

[6]  N. Duan.  Smearing Estimate: A Nonparametric Retransformation Method , 1983 .

[7]  J. O’Connell,et al.  The economic burden of heart failure , 2000, Clinical cardiology.

[8]  Bradley C Martin,et al.  Good and poor adherence: optimal cut-point for adherence measures using administrative claims data , 2009, Current medical research and opinion.

[9]  William T. Abraham,et al.  Focused Update : ACCF / AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults , 2013 .

[10]  F. Andersson,et al.  The health care costs of heart failure in Sweden , 1999, Journal of internal medicine.

[11]  S. De Geest,et al.  Adherence to Long-Term Therapies: Evidence for Action , 2003, European journal of cardiovascular nursing : journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology.

[12]  P. Nimpitakpong,et al.  Estimation of Financial Burden Due to Oversupply of Medications for Chronic Diseases , 2012, Asia-Pacific journal of public health.

[13]  B. Edgren,et al.  Failure of educational videotapes to improve medication compliance in a health maintenance organization. , 1995, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[14]  I. Gradus-Pizlo,et al.  Health care and medication costs and use among older adults with heart failure. , 2004, The American journal of medicine.

[15]  M. Hudson,et al.  Comparison of measures of medication persistency using a prescription drug database. , 2007, American heart journal.

[16]  R. Cooper,et al.  Precipitating factors leading to decompensation of heart failure. Traits among urban blacks. , 1988, Archives of internal medicine.

[17]  Deo S. Bencio,et al.  Medicaid beneficiaries with congestive heart failure: association of medication adherence with healthcare use and costs. , 2009, The American journal of managed care.

[18]  M. Drazner,et al.  2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2013, Journal of the American College of Cardiology.

[19]  S. Wibulpolprasert,et al.  Thailand health profile 2001-2004 , 2004 .

[20]  Rishi Sikka,et al.  Estimating medication persistency using administrative claims data. , 2005, The American journal of managed care.

[21]  C. Callahan,et al.  Association Between Medication Supplies and Healthcare Costs in Older Adults from an Urban Healthcare System , 2000, Journal of the American Geriatrics Society.

[22]  Tiny Jaarsma,et al.  Compliance in heart failure patients: the importance of knowledge and beliefs. , 2006, European heart journal.

[23]  Harlan M Krumholz,et al.  What works in chronic care management: the case of heart failure. , 2009, Health affairs.

[24]  R. Hurley,et al.  Health plan responses to managed care regulation. , 2002, Managed care quarterly.